Access cutting-edge lupus nephritis treatment through this clinical trial at a research site in Iowa City. Study-provided care at no cost to qualified participants.
Access lupus nephritis specialists in Iowa City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lupus nephritis treatment provided free
The purpose of this study is to evaluate the efficacy and safety of rapcabtagene autoleucel (administered once following lymphodepletion) versus Standard of Care (SOC) in patients with systemic lupus erythematosus (SLE) with active, refractory lupus nephritis (LN).
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this lupus nephritis clinical trial in Iowa City, IA
If you're searching for lupus nephritis treatment options in Iowa City, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Iowa City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lupus nephritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.